NASDAQ · BTSGU

BrightSpring Health Services, Inc.. Tangible Equity

$236.32 -$1.94 (-0.81%) 1D Market open
Charting by TradingView

Key Metrics

$50.79B
Market cap
163.90×
P/E · TTM
$13.65B
Revenue · TTM
$309.89M
Net income
EPS · TTM $1.44
Dividend yield —
Free cash flow $412.12M
Beta · 1Y 1.19
EBITDA · TTM —
Gross margin 12.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 1
    The stock moved +10.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap—
Enterprise value$52.40B
Shares outstanding—
52-wk range$68.14 – $255.51
Avg volume · 20D63.4K
Net cash −$1.61B
Book value / share$9.21
IndustryServices-Home Health Care Services
ExchangeNASDAQ
About BrightSpring Health Services, Inc.. Tangible Equity
IPO dateJan 26, 2024
Employees23500

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E163.90
P/S3.72
P/FCF123.25
EV/EBITDA—
EV/Sales3.84
Graham №$17.28

Profitability

Gross 12.2%
Operating 1.6%
Net 2.3%
FCF 3.0%
ROE / ROIC 17.1% · 4.7%

Financial Health

Current ratio1.74
Quick ratio1.38
Debt / equity1.26
Debt / EBITDA —
Net cash −$1.61B
Working capital$1.14B

Cash Flow · TTM

Operating CF $511.51M
Capex −$99.40M
Free cash flow $412.12M
Buybacks $102.85M
Dividends paid —
Shareholder yield 0.2%

Piotroski F-Score

7 / 9
Strong fundamentals · 7 of 9 signals passing

Altman Z-Score

9.7
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$17.28 vs $236.32
Trades 13.7× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings